Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCS
3126
DELISTED
Steelcase
SCS
| $542K | ﹤0.01% |
64,314
+12,401
| +24% | +$95.2K |
|
|
API
3127
Agora
API
$344M
| $541K | ﹤0.01% |
149,535
+40,036
| +37% | +$153K |
|
3128
FIGS
FIGS
$1.82B
| $540K | ﹤0.01% |
87,208
-214,445
| -71% | -$1.65M |
|
3129
Haverty Furniture Companies
HVT
$416M
| $540K | ﹤0.01% |
16,913
+2,034
| +14% | +$69K |
|
3130
TTEC Holdings
TTEC
$122M
| $539K | ﹤0.01% |
14,472
+306
| +2% | +$13.7K |
|
3131
Gold Fields
GFI
$30.4B
| $539K | ﹤0.01% |
40,443
+34,443
| +574% | +$384K |
|
3132
Caribou Biosciences
CRBU
$149M
| $537K | ﹤0.01% |
101,192
-18,899
| -16% | -$118K |
|
|
EH
3133
EHang Holdings
EH
$411M
| $537K | ﹤0.01% |
49,134
| – | – |
|
3134
Donnelley Financial Solutions
DFIN
$1.2B
| $536K | ﹤0.01% |
13,113
+924
| +8% | +$39.3K |
|
3135
Columbia Financial
CLBK
$1.11B
| $535K | ﹤0.01% |
29,287
+20,144
| +220% | +$408K |
|
|
MITA
3136
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
| $532K | ﹤0.01% |
52,033
| – | – |
|
|
JKS
3137
JinkoSolar
JKS
$824M
| $532K | ﹤0.01% |
10,426
-177,202
| -94% | -$9.28M |
|
3138
Cytek Biosciences
CTKB
$557M
| $531K | ﹤0.01% |
57,789
+27,130
| +88% | +$292K |
|
|
IAS
3139
DELISTED
Integral Ad Science
IAS
| $530K | ﹤0.01% |
37,153
-946
| -2% | -$10.6K |
|
|
AMED
3140
DELISTED
Amedisys
AMED
| $529K | ﹤0.01% |
7,198
-6,401
| -47% | -$554K |
|
|
PETWW
3141
DELISTED
Wag! Group Co Warrant
PETWW
| $529K | ﹤0.01% |
239,500
| – | – |
|
3142
CVRx
CVRX
$146M
| $528K | ﹤0.01% |
+56,679
| New | +$750K |
|
|
INVX
3143
Innovex International
INVX
$1.98B
| $528K | ﹤0.01% |
18,391
+1,110
| +6% | +$32.9K |
|
3144
Actinium Pharmaceuticals
ATNM
$25.5M
| $526K | ﹤0.01% |
+55,662
| New | +$588K |
|
3145
AZZ Inc
AZZ
$4.48B
| $526K | ﹤0.01% |
12,743
+804
| +7% | +$32.9K |
|
|
CMRC
3146
Commerce.com Inc Series 1
CMRC
$262M
| $525K | ﹤0.01% |
58,725
-204,969
| -78% | -$2.08M |
|
|
EVBN
3147
DELISTED
Evans Bancorp Inc
EVBN
| $525K | ﹤0.01% |
15,639
-581
| -4% | -$22K |
|
|
RC
3148
Ready Capital
RC
$276M
| $525K | ﹤0.01% |
51,604
-3,573
| -6% | -$41.8K |
|
3149
Abeona Therapeutics
ABEO
$364M
| $523K | ﹤0.01% |
185,638
| – | – |
|
3150
Uranium Energy
UEC
$4.93B
| $523K | ﹤0.01% |
181,714
+86,128
| +90% | +$312K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.